Skip to content

Intervention Model and Empirical Study of Physical Medicine Fusion Training for Patients with Patellar Tendon Terminal Disease

Intervention Model and Empirical Study of Physical Medicine Fusion Training for Patients with Patellar Tendon Terminal Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093565
Enrollment
Unknown
Registered
2024-12-08
Start date
2024-12-08
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patellar tendinopathy

Interventions

Collaborative intervention group (experimental group):The PT collaborative intervention program combines sports, medicine, and education content, including exercise training methods, exercise intensit
Physical therapy group (control group):The physical therapy control group received extracorporeal shock wave therapy (ESWT), with patients in a supine position, knee flexion of 30 °, and a soft pillow
Health education group (control group):Adopting the health education approach in the collaborative inter

Sponsors

Shandong First Medical University Affiliated Neck, Shoulder, Waist, and Leg Pain Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. VISA P score<80 points (out of 100 points); 2.Meets PT diagnostic criteria; 3. At least six months of pain history; 4. The knee extension resistance test or single foot squat test is positive; 5. Heart, lung, brain, and mental illnesses; 6. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Acute knee or patellar tendon injury; 2. Late PT; 3. History of knee surgery; 4. Known hip and ankle inflammatory joint disease or familial hypercholesterolemia; 5. Use of drugs that have an effect on the patellar tendon (e.g., fluoroquinolones) within the past year; 6. Corticosteroid injections in or around the patellar tendon within the past month; 7. History of patellar tendon rupture; 8. Those who have used treatments that may affect the efficacy of this trial in the past two weeks (including exercise therapy); 9. Inability to walk or walk distance < 300m or unable to perform exercise training plan; 10. Physical examination or ultrasound/MRI showing other signs or symptoms of comorbid knee joint pathology and contraindications to MRI; 11. Have regular exercise habits; 12. Those with severe cardiovascular and cerebrovascular diseases, history of mental illness, cognitive impairment and contraindications to exercise therapy; 13. Those who are participating in other clinical trials and will affect the results of this study.

Design outcomes

Primary

MeasureTime frame
VAS pain score;Joint range of motion;Muscle Strength;Proprioceptive threshold;Foot tactile threshold;Berg Balance Score;Counter movement jump;VISA-P;

Countries

China

Contacts

Public ContactLiu Wei

Shandong First Medical University Affiliated Neck, Shoulder, Waist, and Leg Pain Hospital

34559516@qq.com+86 186 6370 8777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026